Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

HISTOPATHOLOGY SERVICES INC

NPI: 1699085290 · TUSTIN, CA 92780 · Clinical Medical Laboratory · NPI assigned 10/15/2010

$968K
Total Medicaid Paid
21,440
Total Claims
21,055
Beneficiaries
6
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialMEHRAEIN, KHODADAD (PRESIDENT/CEO)
NPI Enumeration Date10/15/2010

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 195 $961.73
2019 788 $6K
2020 1,643 $40K
2021 1,224 $34K
2022 3,440 $141K
2023 8,379 $419K
2024 5,771 $327K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 4,720 4,630 $384K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,600 7,377 $332K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,482 2,434 $138K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,919 2,900 $90K
88312 2,070 2,067 $21K
88311 1,649 1,647 $4K